Clinical lipoatrophy in HIV‐1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance

Dorte Worm(University of Copenhagen), C Pedersen(Sennheiser (Germany)), Henrik Nielsen(Aalborg University Hospital), Terese L. Katzenstein, Jan Gerstoft, Ove Andersen(University of Copenhagen), J. Vinten(Statens Serum Institut), Ole Kirk(University of Copenhagen)
HIV Medicine
July 1, 2002
10.1046/j.1468-1293.2002.00125.x
Cited by 15

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930